Penetration of Stem Cell Therapy in APAC Region

• Singapore has the highest penetration for stem cell therapy, achieving almost 25% penetration rate by 2010.

• Both Thailand & Taiwan have similar penetration rates achieving overall penetration of almost 4% by 2010.

• Malaysia on the other hand has a relatively lower penetration rate at 1.2% by 2010.

• India offers penetration of 5% by 2010 largely accounted by stem cell therapies derived out of cord blood banking. It has
  three international players already creating a headstart.

• In the APAC regions, Singapore has the highest penetration with a CAGR of almost 66% for market penetration over the next five years. Malaysia leads second with a CAGR of 33%. Taiwan & Thailand lead on the basis of sheer numbers, but would have a comparatively lower demand trajectory due to restrictive healthcare policies. Source: Stempeutics